BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2005
View Archived Issues
Immune modulation therapy with Celacade benefits heart failure patients
Read More
Oral pimecrolimus reported effective in moderate to severe atopic dermatitis
Read More
Patupilone activity, safety gauged in phase I/II trial in non-small cell lung cancer
Read More
OGX-011 reported to be well tolerated when added to NSCLC chemotherapy
Read More
Malignant pleural mesothelioma patients achieve disease control with vinflunine
Read More
Caspase inhibitor prevents plaque progression in atherosclerotic mice
Read More
Novel adenosine A3 receptor antagonists reported
Read More
NO moiety in statins improves their therapeutic potential
Read More
Priority review for Exjade in Canada
Read More
SPA agreement for phase III study of renzapride for c-IBS
Read More
7TM Pharma begins phase I/II trials for TM-30338 for obesity
Read More
Astex Technology changes name to Astex Therapeutics
Read More
Albany Molecular Research partners with NINDS in spinal muscular atrophy
Read More
Tracleer study shows benefit in Eisenmenger's syndrome
Read More
Phase IIIb/IV ASSENT 4 PCI study of tenecteplase stopped early
Read More
MVA smallpox vaccine MVA-3000 begins phase II trial
Read More
Pagoclone studied in phase II trial for persistent developmental stuttering
Read More
Triglide launched in U.S.
Read More
VNS Therapy System receives FDA approval for treatment-resistant depression
Read More
Thelin NDA receives March 2006 action date
Read More
MATCHED study of MC-4232 completes treatment period
Read More
Novartis to acquire Bristol-Myers Squibb's OTC portfolio
Read More
Prous Science announces publication of a comprehensive review on Behcet's disease
Read More
NMP22 BladderChek Test approved in Japan
Read More
Recent patents cover therapeutic agents for cognitive impairment and neurodegeneration
Read More
Novel antithrombotic agents reported in recent patent literature
Read More